(Q100157869)

English

Phase III Trial of A COVID-19 Vaccine of Adenovirus Vector in Adults 18 Years Old and Above

clinical trial

In more languages

edit

Statements

instance of

clinical trial

0 references

title

A Global Multicenter, Randomized, Double-blind, Placebo -Controlled, Adaptive Designed Phase Ⅲ Clinical Trial to Evaluate the Efficacy, Safety and Immunogenicity of Ad5-nCoV in Adults 18 Years of Age and Older (English)

0 references

country

Pakistan

0 references

start time

15 September 2020

0 references

end time

20 December 2021

0 references

number of participants

40,000

0 references

clinical trial phase

phase III clinical trial

0 references

Identifiers

ClinicalTrials.gov ID

NCT04526990

0 references

(Q100157869)

Phase III Trial of A COVID-19 Vaccine of Adenovirus Vector in Adults 18 Years Old and Above

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)